The dose of the first- or second-generation β blocker that the patient is receiving is an important consideration for the switching regimen chosen. The major factors to be kept in mind when ...
Even more specifically, there are two types of beta blockers: cardioselective and non-selective. The former targets receptors in the heart while the latter affects both heart sensors and others ...
Nebivolol (Bystolic®), a novel, highly cardioselective, third-generation β-blocker that recently received approval by the US FDA for the treatment of hypertension in the USA, is effective in ...